Merck KGaA CEO says investment strategy in China has not changed

LONDON (Reuters) - German diversified healthcare and chemicals group Merck KGaA's investment strategy in China has not changed, but potential risks that may emerge in coming years need to be taken into account, its CEO said on Thursday.

(Reporting by Ludwig Burger in Frankfurt and Natalie Grover in London; Editing by Jan Harvey)